• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血型Gb3增加法布里肾病中培养的人足细胞中αvβ3整合素基因的表达。

Lyso-Gb3 Increases αvβ3 Integrin Gene Expression in Cultured Human Podocytes in Fabry Nephropathy.

作者信息

Trimarchi Hernán, Ortiz Alberto, Sánchez-Niño Maria Dolores

机构信息

Nephrology Service, Hospital Británico de Buenos Aires, 1280 Buenos Aires, Argentina.

IIS-Fundación Jimenez Díaz, School of Medicine, UAM, 28040 Madrid, Spain.

出版信息

J Clin Med. 2020 Nov 13;9(11):3659. doi: 10.3390/jcm9113659.

DOI:10.3390/jcm9113659
PMID:33203029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7696179/
Abstract

BACKGROUND

Podocyturia in Fabry nephropathy leads to glomerulosclerosis and kidney disease progression. Integrins are involved in podocyte attachment to the glomerular basement membrane. We hypothesized that in Fabry nephropathy, lyso-Gb3 could modulate αvβ3 expression in podocytes. Together with UPAR, the αvβ3 integrin is a key mechanism involved in podocyte detachment and podocyturia.

METHODS

In cultured human podocytes stimulated with lyso-Gb3, the mRNA expression of the and genes encoding integrins αv and β3, respectively, was analyzed by RT-qPCR.

RESULTS

In cultured human podocytes, lyso-Gb3 at concentrations encountered in the serum of Fabry patients increased and mRNA levels within 3 to 6 h. This pattern of gene expression is similar to that previously observed for gene expression but is in contrast to the delayed (24 h) upregulation of other markers of podocyte stress and mediators of injury, such as CD80, TGFβ1, CD74, Notch1, and HES.

CONCLUSIONS

Human podocyte stress in response to glycolipid overload in Fabry nephropathy, exemplified by lyso-Gb3, is characterized by an early increase in the expression of components of the αvβ3/UPAR system, which contrasts with the delayed rise in the expression of other mediators of podocyte injury. This suggests that the αvβ3/UPAR system may be a therapeutic target in Fabry nephropathy.

摘要

背景

法布里肾病中的足细胞尿可导致肾小球硬化和肾脏疾病进展。整合素参与足细胞与肾小球基底膜的附着。我们推测,在法布里肾病中,溶血型Gb3可调节足细胞中αvβ3的表达。αvβ3整合素与尿激酶型纤溶酶原激活物受体(UPAR)一起,是参与足细胞脱离和足细胞尿的关键机制。

方法

在用溶血型Gb3刺激的培养人足细胞中,通过逆转录定量聚合酶链反应(RT-qPCR)分析分别编码整合素αv和β3的 和 基因的mRNA表达。

结果

在培养的人足细胞中,法布里病患者血清中存在的浓度的溶血型Gb3在3至6小时内增加了 和 的mRNA水平。这种基因表达模式与先前观察到的 基因表达模式相似,但与足细胞应激和损伤介质(如CD80、转化生长因子β1、CD74、Notch1和HES)的延迟(24小时)上调形成对比。

结论

以溶血型Gb3为例,法布里肾病中糖脂过载引起的人足细胞应激的特征是αvβ3/UPAR系统成分的表达早期增加,这与足细胞损伤的其他介质表达的延迟增加形成对比。这表明αvβ3/UPAR系统可能是法布里肾病的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/11e9a6b9e11e/jcm-09-03659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/221dad3536df/jcm-09-03659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/94fb5f4a110a/jcm-09-03659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/fda610326e48/jcm-09-03659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/11e9a6b9e11e/jcm-09-03659-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/221dad3536df/jcm-09-03659-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/94fb5f4a110a/jcm-09-03659-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/fda610326e48/jcm-09-03659-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3029/7696179/11e9a6b9e11e/jcm-09-03659-g004.jpg

相似文献

1
Lyso-Gb3 Increases αvβ3 Integrin Gene Expression in Cultured Human Podocytes in Fabry Nephropathy.溶血型Gb3增加法布里肾病中培养的人足细胞中αvβ3整合素基因的表达。
J Clin Med. 2020 Nov 13;9(11):3659. doi: 10.3390/jcm9113659.
2
Lyso-Gb3 activates Notch1 in human podocytes.溶血神经节苷脂三己糖苷(Lyso-Gb3)激活人足细胞中的Notch1。
Hum Mol Genet. 2015 Oct 15;24(20):5720-32. doi: 10.1093/hmg/ddv291. Epub 2015 Jul 23.
3
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.法布里病患者尿足细胞中尿激酶型纤溶酶原激活物受体的表达
Int J Nephrol. 2017;2017:1287289. doi: 10.1155/2017/1287289. Epub 2017 Apr 24.
4
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy.神经酰胺三己糖苷对人肾小球足细胞的作用:对法布里肾病的启示。
Nephrol Dial Transplant. 2011 Jun;26(6):1797-802. doi: 10.1093/ndt/gfq306. Epub 2010 May 26.
5
Increased urinary CD80 excretion and podocyturia in Fabry disease.法布里病患者尿中CD80排泄增加及足细胞尿。
J Transl Med. 2016 Oct 13;14(1):289. doi: 10.1186/s12967-016-1049-8.
6
Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes.法布里病患者尿足细胞中足萼蛋白与突触素比例的早期下降
Clin Kidney J. 2019 Feb;12(1):53-60. doi: 10.1093/ckj/sfy053. Epub 2018 Jul 20.
7
RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death.RIPK3 促进溶酶体糖脂(Gb3)诱导的足细胞死亡。
Cells. 2021 Jan 27;10(2):245. doi: 10.3390/cells10020245.
8
In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia.在IgA肾病中,肾小球硬化与尿CD80排泄增加及尿激酶型纤溶酶原激活物受体阳性足细胞尿有关。
Nephron Extra. 2017 May 16;7(2):52-61. doi: 10.1159/000473888. eCollection 2017 May-Aug.
9
MiR-30 family prevents uPAR-ITGB3 signaling activation through calcineurin-NFATC pathway to protect podocytes.miR-30 家族通过钙调神经磷酸酶-NFATC 通路防止 uPAR-ITGB3 信号激活,从而保护足细胞。
Cell Death Dis. 2019 May 24;10(6):401. doi: 10.1038/s41419-019-1625-y.
10
Podocyturia: why it may have added value in rare diseases.足细胞尿:为何它可能在罕见病中具有附加价值。
Clin Kidney J. 2018 Oct 5;12(1):49-52. doi: 10.1093/ckj/sfy081. eCollection 2019 Feb.

引用本文的文献

1
Genome-wide expression analysis in a Fabry disease human podocyte cell line.法布里病人类足细胞系的全基因组表达分析。
Heliyon. 2024 Jul 9;10(14):e34357. doi: 10.1016/j.heliyon.2024.e34357. eCollection 2024 Jul 30.
2
Role of the Innate Immune Response in Glomerular Disease Pathogenesis: Focus on Podocytes.固有免疫反应在肾小球疾病发病机制中的作用:聚焦于足细胞。
Cells. 2024 Jul 6;13(13):1157. doi: 10.3390/cells13131157.
3
Normal and Dysregulated Sphingolipid Metabolism: Contributions to Podocyte Injury and Beyond.正常和失调的神经鞘脂代谢:对足细胞损伤的影响及其他作用。

本文引用的文献

1
Tacrolimus Prevents TWEAK-Induced PLA2R Expression in Cultured Human Podocytes.他克莫司可预防TWEAK诱导的人足细胞培养物中PLA2R的表达。
J Clin Med. 2020 Jul 10;9(7):2178. doi: 10.3390/jcm9072178.
2
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study.法布里病男性和女性患者中p.Asn215Ser(p.N215S)GLA突变的表型特征:一项多中心法布里病注册研究。
Mol Genet Genomic Med. 2018 Apr 12;6(4):492-503. doi: 10.1002/mgg3.389.
3
Fabry disease revisited: Management and treatment recommendations for adult patients.
Cells. 2024 May 22;13(11):890. doi: 10.3390/cells13110890.
4
Molecular Mechanisms of Kidney Injury and Repair.肾脏损伤与修复的分子机制
Int J Mol Sci. 2022 Jan 28;23(3):1542. doi: 10.3390/ijms23031542.
5
Podocyturia in Fabry disease: a 10-year follow-up.法布里病中的足细胞尿:一项10年随访研究
Clin Kidney J. 2021 Sep 16;15(2):269-277. doi: 10.1093/ckj/sfab172. eCollection 2022 Feb.
6
Renal involvement in a patient with the chronic visceral subtype of acid sphingomyelinase deficiency resembles Fabry disease.酸性鞘磷脂酶缺乏慢性内脏亚型患者的肾脏受累类似于法布里病。
JIMD Rep. 2021 Jul 26;62(1):15-21. doi: 10.1002/jmd2.12242. eCollection 2021 Nov.
7
Pathogenesis and Molecular Mechanisms of Anderson-Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies.安德森-法布里病的发病机制和分子机制及可能的新分子靶向治疗策略。
Int J Mol Sci. 2021 Sep 18;22(18):10088. doi: 10.3390/ijms221810088.
重新审视法布里病:成年患者的管理和治疗建议。
Mol Genet Metab. 2018 Apr;123(4):416-427. doi: 10.1016/j.ymgme.2018.02.014. Epub 2018 Feb 28.
4
Albumin downregulates Klotho in tubular cells.白蛋白下调肾小管细胞 Klotho。
Nephrol Dial Transplant. 2018 Oct 1;33(10):1712-1722. doi: 10.1093/ndt/gfx376.
5
Podocytes are new cellular targets of haemoglobin-mediated renal damage.足细胞是血红蛋白介导的肾脏损伤的新的细胞靶标。
J Pathol. 2018 Mar;244(3):296-310. doi: 10.1002/path.5011. Epub 2018 Jan 10.
6
Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.长期剂量依赖性阿加糖酶α对法布雷病肾脏组织学的影响。
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1470-1479. doi: 10.2215/CJN.01820217. Epub 2017 Jun 16.
7
Expression of uPAR in Urinary Podocytes of Patients with Fabry Disease.法布里病患者尿足细胞中尿激酶型纤溶酶原激活物受体的表达
Int J Nephrol. 2017;2017:1287289. doi: 10.1155/2017/1287289. Epub 2017 Apr 24.
8
Podocyturia: What is in a name?足细胞尿:名称里有什么含义?
J Transl Int Med. 2015 Apr-Jun;3(2):51-56. doi: 10.1515/jtim-2015-0003. Epub 2015 Jun 30.
9
Increased urinary CD80 excretion and podocyturia in Fabry disease.法布里病患者尿中CD80排泄增加及足细胞尿。
J Transl Med. 2016 Oct 13;14(1):289. doi: 10.1186/s12967-016-1049-8.
10
Podocyte injury and its consequences.足细胞损伤及其后果。
Kidney Int. 2016 Jun;89(6):1221-30. doi: 10.1016/j.kint.2016.01.012. Epub 2016 Mar 19.